| Cash and cash equivalents | 154.14M |
| Available-for-sale securities | 129.45M |
| Inventories | 11.26M |
| Prepaid expenses and other assets | 5.55M |
| Current assets of discontinued operations | |
| Total current assets | 310.69M |
| Property and equipment, net | 715K |
| Total assets | 313.15M |
| Accounts payable | 6.44M |
| Accrued research and clinical expenses | |
| Accrued employee compensation and benefits | |
| Accrued and other liabilities | 9.94M |
| Current liabilities of discontinued operations | |
| Total current liabilities | 114.53M |
| Commitments and contingencies | 0 |
| Preferred stock; $1.00 par value; 5,000 shares authorized; no shares issued and outstanding | 0 |
| Common stock; $.001 par value; 200,000 shares authorized; 81,971 and 81,568 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively | 105K |
| Additional paid-in capital | 831.19M |
| Accumulated other comprehensive income | 207K |
| Accumulated deficit | -869.62M |
| Total stockholders' equity | |
| Total liabilities and stockholders' equity | 313.15M |